The current first-line chemotherapy protocol for PC is gemcitabine (GEM) plus paclitaxel-albumin and FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan, and oxaliplatin), which are the mainstays of treatment for patients with advanced PC[4, 54]. The gene discussed is ALB; the disease is pachyonychia congenita.